NCT01503814 - Simplified Cardiovascular Management Study | Biotech Hunter

Enrollment

2,086

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

September 30, 2015

Conditions

Cardiovascular Disease

Interventions

OTHER

Simplified cardiovascular disease management

"This study is a complex pragmatic trial.The intervention includes a package of 4 main established measures for cardiovascular prevention and management:~2 therapeutic lifestyle recommendations- smoking cessation (if applicable) and reduced salt consumption~2 drug therapies (if applicable)- hydrochlorothiazide, 25mg tab, 1/2 tab daily (12.5mg/day) and aspirin, 25mg tab, 3 tabs daily (75mg/day)"

Trial Locations (3)

Unknown

Linzhou, Lhasa

Gongbujiangda, Linzhi

Faridabad, Haryāna

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH